Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Mycobacterium tuberculosis survival and biofilm formation studies: effect of d-amino acids, d-cycloserine and its components

The Journal of Antibiotics volume 75, pages 472–479 (2022)Cite this article

Subjects

Abstract

d-amino acids play an important role in cell wall peptidoglycan biosynthesis. Mycobacterium tuberculosis d-amino acid oxidase deletion led to reduced biofilm-forming ability. Other recent studies also suggest that the accumulation of d-amino acids blocks biofilm formation and could also disperse pre-formed biofilm. Biofilms are communities of bacterial cells protected by extracellular matrix and harbor drug-tolerant as well as persistent bacteria. In Mycobacterium tuberculosis, biofilm formation or its inhibition by d-amino acids is yet to be tested. In the present study, we used selected d-amino acids to study their role in the prevention of biofilm formation and also if d-cycloserine’s activity was due to presence of d-Serine as a metabolite. It was observed that d-serine limits biofilm formation in Mycobacterium tuberculosis H37Ra (Mtb-Ra), but it shows no effect on pre-formed biofilm. Also, d-cycloserine and its metabolic product, hydroxylamine, individually and in combination, with d-Serine, limit biofilm formation in Mtb-Ra and also disrupts existing biofilm. In summary, we demonstrated that d-alanine, d-valine, d-phenylalanine, d-serine, and d-threonine had no disruptive effect on pre-formed biofilm of Mtb-Ra, either individually or in combination, and d-cycloserine and its metabolite hydroxylamine have potent anti-biofilm activity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. World Health Organization, 2020. Global tuberculosis report 2020. In: Global tuberculosis report. 2020.

  2. Boshoff HI, Barry CE. Tuberculosis—metabolism and respiration in the absence of growth. Nat Rev Microbiol. 2005;3:70–80.

    Article  CAS  Google Scholar 

  3. Wayne LG, Sohaskey CD. Nonreplicating persistence of Mycobacterium tuberculosis. Annu Rev Microbiol. 2001;55:139–63.

    Article  CAS  Google Scholar 

  4. Basaraba RJ, Ojha AK. Mycobacterial biofilms:revisiting tuberculosis bacilli in extracellular necrotizing lesions. Microbiol Spectrum. 2017;5. https://doi.org/10.1128/microbiolspec.TBTB2-0024-2016.

  5. Islam MS, Richards JP, Ojha AK. Targeting drug tolerance in mycobacteria: a perspective from mycobacterial biofilms. Expert Rev Aanti-infective Ther. 2012;10:1055–66.

    Article  CAS  Google Scholar 

  6. Flemming HC, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S. Biofilms: an emergent form of bacterial life. Nat Rev Microbiol. 2016;14:563.

    Article  CAS  Google Scholar 

  7. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999;37:1771–6.

    Article  CAS  Google Scholar 

  8. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–22.

    Article  CAS  Google Scholar 

  9. Costerton JW, Geesey GG, Cheng KJ. How bacteria stick. Sci Am. 1978;238:86–95.

    Article  CAS  Google Scholar 

  10. Aung TT, Yam JKH, Lin S, Salleh SM, Givskov M, Liu S, Lwin NC, Yang L, Beuerman RW. Biofilms of pathogenic nontuberculous mycobacteria targeted by new therapeutic approaches. Antimicrob Agents Chemother. 2016;60:24–35.

    Article  CAS  Google Scholar 

  11. Carter G, Wu M, Drummond DC, Bermudez LE. Characterization of biofilm formation by clinical isolates of Mycobacterium avium. J Med Microbiol. 2003;52:747–52.

    Article  CAS  Google Scholar 

  12. Chakraborty P, Kumar A. The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections? Microb Cell. 2019;6:105.

    Article  CAS  Google Scholar 

  13. Ojha AK, Baughn AD, Sambandan D, Hsu T, Trivelli X, Guerardel Y, Alahari A, Kremer L, Jacobs WR Jr, Hatfull GF. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug‐tolerant bacteria. Mol Microbiol. 2008;69:164–74.

    Article  CAS  Google Scholar 

  14. Kolodkin-Gal I, Romero D, Cao S, Clardy J, Kolter R, Losick R. D-amino acids trigger biofilm disassembly. Science. 2010;328:627–9.

    Article  CAS  Google Scholar 

  15. Singh KS, Kumar R, Chauhan A, Singh N, Sharma R, Singh D, Singh SK. Knockout of MRA_1916 in Mycobacterium tuberculosis H37Ra affects its growth, biofilm formation, survival in macrophages and in mice. Tuberculosis. 2021;128:102079.

    Article  CAS  Google Scholar 

  16. Hochbaum AI, Kolodkin-Gal I, Foulston L, Kolter R, Aizenberg J, Losick R. Inhibitory effects of D-amino acids on Staphylococcus aureus biofilm development. J Bacteriol. 2011;193:5616–22.

    Article  CAS  Google Scholar 

  17. Aliashkevich A, Laura A, Cava F. New insights into the mechanisms and biological roles of D-amino acids in complex eco-systems. Front Microbiol. 2018;9:1–11.

    Article  Google Scholar 

  18. Horcajo P, de Pedro MA, Cava F. Peptidoglycan plasticity in bacteria: stress-induced peptidoglycan editing by noncanonical D-amino acids. Microb Drug Resist. 2012;18:306–13.

    Article  CAS  Google Scholar 

  19. Lam H, Oh DC, Cava F, Takacs CN, Clardy J, de Pedro MA, Waldor MK. D-amino acids govern stationary phase cell wall remodeling in bacteria. Science. 2009;325:1552–5.

    Article  CAS  Google Scholar 

  20. Brandenburg KS, Rodriguez KJ, McAnulty JF, Murphy CJ, Abbott NL, Schurr MJ, Czuprynski CJ. Tryptophan inhibits biofilm formation by Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2013;57:1921–5.

    Article  CAS  Google Scholar 

  21. Lambert MP, Neuhaus FC. Mechanism of D-cycloserine action: alanine racemase from Escherichia coli W. J Bacteriol. 1972;110:978–87.

    Article  CAS  Google Scholar 

  22. Prosser GA, de Carvalho LPS. Kinetic mechanism and inhibition of Mycobacterium tuberculosis d‐alanine: d‐alanine ligase by the antibiotic d‐cycloserine. FEBS J. 2013;280:1150–66.

    Article  CAS  Google Scholar 

  23. Kaushal G, Ramirez R, Alambo D, Taupradist W, Choksi K, Sirbu C. Initial characterization of D-cycloserine for future formulation development for anxiety disorders. Drug Discov Ther. 2011;5:253–60.

    Article  CAS  Google Scholar 

  24. Olson GT, Fu M, Lau S, Rinehart KL, Silverman RB. An aromatization mechanism of inactivation of γ-aminobutyric acid aminotransferase for the antibiotic L-cycloserine. J Am Chem Soc. 1998;120:2256–67.

    Article  CAS  Google Scholar 

  25. Zhao T, Liu Y. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol. 2010;10:140.

    Article  CAS  Google Scholar 

  26. Malspeis L, Gold D. Stability of cycloserine in buffered aqueous solutions. J Pharm Sci. 1964;53:1173–80.

    Article  CAS  Google Scholar 

  27. Doern CD. When does 2 plus 2 equal 5? A review of antimicrobial synergy testing. J Clin Microbiol. 2014;52:4124–8.

    Article  Google Scholar 

  28. Ghosh S, Qureshi A, Purohit HJ. D-Tryptophan governs biofilm formation rates and bacterial interaction in P. mendocina and S. aureus. J Biosci. 2019;44:3.

    Article  Google Scholar 

  29. Caminero JA, Sotgiu G, Zumla A, Migliori GB. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis. 2010;10:621–9.

    Article  CAS  Google Scholar 

  30. Strych U, Penland RL, Jimenez M, Krause KL, Benedik MJ. Characterization of the alanine racemases from two mycobacteria. FEMS Microbiol Lett. 2001;196:93–8.

    Article  CAS  Google Scholar 

  31. Bruning JB, Murillo AC, Chacon O, Barletta RG, Sacchettini JC. Structure of the Mycobacterium tuberculosis D-alanine: D-alanine ligase, a target of the antituberculosis drug D-cycloserine. Antimicrob Agents Chemother. 2011;55:291–301.

    Article  CAS  Google Scholar 

  32. Marchese A, Bozzolasco M, Gualco L, Debbia EA, Schito GC, Schito AM. Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. Int J Antimicrob Agents. 2003;22:95–100.

    Article  Google Scholar 

  33. Singh KS, Sharma R, Keshari D, Singh N, Singh SK. Down-regulation of malate synthase in Mycobacterium tuberculosis H37Ra leads to reduced stress tolerance, persistence and survival in macrophages. Tuberculosis. 2017;106:73–81.

    Article  CAS  Google Scholar 

  34. Saiman L. Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: ‘the motion for’. Paediatr Respir Rev. 2007;8:249–55.

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge funding support from SERB (Grant no. EMR/20l7/001295) and CSIR-CDRI (Grant no. MLP2033). RK is a recipient of JRF from DBT, New Delhi, India. NS, AC and MK were supported by JRF from UGC, New Delhi, India. The LC-MS/MS studies were performed at Pharmaceutics and Pharmacokinetics division of CSIR-CDRI. This manuscript is CSIR-CDRI communication no. 10404.

Author information

Author notes

  1. These authors contributed equally: Nirbhay Singh, Anu Chauhan

Authors and Affiliations

  1. Molecular Microbiology and Immunology Division, CSIR-Central Drug Research Institute, B.S. 10/1, Sector-10, Jankipuram Extension, Sitapur Road, Lucknow, 226031, India

    Ram Kumar, Nirbhay Singh, Anu Chauhan & Sudheer Kumar Singh

  2. Jawaharlal Nehru University, New Mehrauli Road, JNU Ring Rd, New Delhi, 110067, India

    Ram Kumar, Nirbhay Singh & Mukesh Kumar

  3. Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India

    Anu Chauhan & Sudheer Kumar Singh

  4. Pharmaceutics and Pharmacokinetics Division, CSIR-Central Drug Research Institute, B.S. 10/1, Sector-10, Jankipuram Extension, Sitapur Road, Lucknow, 226031, India

    Mukesh Kumar & Rabi Sankar Bhatta

Authors
  1. Ram Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nirbhay Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anu Chauhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mukesh Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rabi Sankar Bhatta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sudheer Kumar Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SKS did the planning of experiments and analyzed the data. RK performed most of the experiments, prepared figures and did major writing work. NS and AC contributed to survival studies. MK and RSB contributed to LC-MS/MS studies. All the authors reviewed the manuscript.

Corresponding author

Correspondence to Sudheer Kumar Singh.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kumar, R., Singh, N., Chauhan, A. et al. Mycobacterium tuberculosis survival and biofilm formation studies: effect of d-amino acids, d-cycloserine and its components. J Antibiot 75, 472–479 (2022). https://doi.org/10.1038/s41429-022-00534-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41429-022-00534-6

Search

Advanced search

Quick links